V
42.61
1.35 (3.27%)
| Penutupan Terdahulu | 41.26 |
| Buka | 41.18 |
| Jumlah Dagangan | 1,900,361 |
| Purata Dagangan (3B) | 1,572,677 |
| Modal Pasaran | 2,723,974,912 |
| Harga / Buku (P/B) | 5.41 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Nov 2025 |
| EPS Cair (TTM) | -3.00 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 10.18% |
| Nisbah Semasa (MRQ) | 27.68 |
| Aliran Tunai Operasi (OCF TTM) | -155.26 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -97.14 M |
| Pulangan Atas Aset (ROA TTM) | -23.46% |
| Pulangan Atas Ekuiti (ROE TTM) | -39.49% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Vera Therapeutics, Inc. | Menaik | Menurun |
AISkor Stockmoo
0.0
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | -4.0 |
| Volatiliti Harga | -3.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 4.0 |
| Purata | 0.00 |
|
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 3.97% |
| % Dimiliki oleh Institusi | 112.39% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 90.00 (HC Wainwright & Co., 111.22%) | Beli |
| Median | 62.50 (46.68%) | |
| Rendah | 48.00 (B of A Securities, 12.65%) | Beli |
| Purata | 65.75 (54.31%) | |
| Jumlah | 4 Beli | |
| Harga Purata @ Panggilan | 31.27 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| TD Cowen | 05 Dec 2025 | 73.00 (71.32%) | Beli | 42.61 |
| HC Wainwright & Co. | 10 Nov 2025 | 90.00 (111.22%) | Beli | 27.75 |
| JP Morgan | 07 Nov 2025 | 52.00 (22.04%) | Beli | 24.19 |
| B of A Securities | 16 Oct 2025 | 48.00 (12.65%) | Beli | 30.51 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| TURNER WILLIAM D. | - | 41.26 | -10,000 | -412,600 |
| Jumlah Keseluruhan Kuantiti Bersih | -10,000 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -412,600 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 41.26 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| TURNER WILLIAM D. | Pegawai | 03 Dec 2025 | Jual automatik (-) | 10,000 | 41.26 | 412,600 |
| TURNER WILLIAM D. | Pegawai | 03 Dec 2025 | Pelaksanaan pilihan | 10,000 | - | - |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |